Antibodies

05 Mar 2008 Phase I/II Studies of IMC-A12 in Pediatric Cancer Patients Commence Enrollment
05 Mar 2008 Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
04 Mar 2008 UCB: Early Data on Cimzia(R) from the WELCOME Study Show Efficacy in Infliximab-Refractory Crohn's Disease Patients
04 Mar 2008 Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
03 Mar 2008 BioWa Announces Expansion of License Agreement With Genetech for BioWa's POTELLIGENT(R) Technology
03 Mar 2008 Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
29 Feb 2008 Herceptin approved in Japan for early treatment in patients with HER2-positive breast cancer
27 Feb 2008 MorphoSys and Sigma-Aldrich Enter into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
27 Feb 2008 FDA Approves Regeneron's ARCALYST(TM) (rilonacept) for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
26 Feb 2008 Bradmer announces phase ii results published in newly diagnosed Glioblastoma which demonstrate improved survival and support upcoming Phase III study
25 Feb 2008 ESBATech's Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery Via Eye Drops
22 Feb 2008 FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer
22 Feb 2008 Phase II Study of IMC-1121B for Advanced Liver Cancer Commences Patient Enrollment
22 Feb 2008 Abbott Receives FDA Approval for HUMIRA® (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
22 Feb 2008 Comparison of AMD Treatments Trials (CATT): Lucentis — Avastin Trial
21 Feb 2008 Antisoma starts phase I clinical trial of AS1409 in renal cancer and melanoma
21 Feb 2008 MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel Antibody Therapies
20 Feb 2008 Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-011 Program for Cancer-Related Bone Loss
20 Feb 2008 InNexus Biotechnology Announces Second Preclinical Candidate DXL702 (HER2/neu) Targeting Breast Cancer
19 Feb 2008 Biolex Therapeutics Enters Into Agreement With Merck KGaA for Antibody Optimization
18 Feb 2008 Takeda Discontinues Development of Matuzumab
18 Feb 2008 EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
14 Feb 2008 Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint
13 Feb 2008 YM BioSciences USA Enrolls First Patient in Phase II Trial of Nimotuzumab in Children with Inoperable, Recurrent Brain Caincer
13 Feb 2008 Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top